Krystal Biotech, Inc. Annual Depreciation in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Krystal Biotech, Inc. quarterly/annual Depreciation history and growth rate from 2016 to 2023.
  • Krystal Biotech, Inc. Depreciation for the quarter ending June 30, 2024 was $1.8M, a 50% increase year-over-year.
  • Krystal Biotech, Inc. Depreciation for the twelve months ending June 30, 2024 was $5.94M, a 49.3% increase year-over-year.
  • Krystal Biotech, Inc. annual Depreciation for 2023 was $5.01M, a 89.4% increase from 2022.
  • Krystal Biotech, Inc. annual Depreciation for 2022 was $2.64M, a 42.9% increase from 2021.
  • Krystal Biotech, Inc. annual Depreciation for 2021 was $1.85M, a 23.3% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $5.01M +$2.36M +89.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-26
2022 $2.64M +$794K +42.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-26
2021 $1.85M +$349K +23.3% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-26
2020 $1.5M +$752K +101% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 $748K +$607K +430% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-01
2018 $141K +$118K +513% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-10
2017 $23K +$21K +1050% Jan 1, 2017 Dec 31, 2017 10-K 2018-03-12
2016 $2K Jan 1, 2016 Dec 31, 2016 10-K 2018-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.